Soluplus launched as market for HME excipients heats up
BASF says its new Soluplus excipient will help meet demand for solubilising agents that are compatible with hot melt extrusion (HME) manufacturing methods.
BASF says its new Soluplus excipient will help meet demand for solubilising agents that are compatible with hot melt extrusion (HME) manufacturing methods.
Health Decisions is “effectively franchising” its clinical trial model to other CROs to create a network of partners that it believes will offer “great flexibility” to clients, according to its COO.
GEA Niro has begun offering contract spray-drying services for drug candidates and clinical trial supplies from its “Test Center” in Copenhagen, Denmark and wants the drug industry to know about the technique’s advantages.
Comparative effectiveness research (CER) represents a “historical market opportunity”, according to a VP at Quintiles who explained that pharmas that do the work will be “properly rewarded for their innovations”.
IMS Health has confirmed it is “exploring strategic alternatives” after speculation this week suggested that the market analysis group had received a number of takeover bids.
The CRO results season is underway with Icon and Covance both posting mixed Q3 figures as the challenges facing pharma, and businesses in general, continue to impact on operations.